المؤلفون: Tefferi A; Division of Hematology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Lasho TL; Division of Hematology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Finke C; Division of Hematology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Gangat N; Division of Hematology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Hanson CA; Division of Hematopathology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Ketterling RP; Division of Cytogenetics, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Pardanani A; Division of Hematology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

المصدر: Leukemia [Leukemia] 2018 Mar; Vol. 32 (3), pp. 837-839. Date of Electronic Publication: 2017 Nov 01.

نوع المنشور: Letter

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Alleles* , Mutation*, Primary Myelofibrosis/*genetics , Primary Myelofibrosis/*mortality , Repressor Proteins/*genetics, Exons ; Humans ; Primary Myelofibrosis/diagnosis ; Prognosis ; Protein Interaction Domains and Motifs ; Repressor Proteins/chemistry

المؤلفون: Tefferi A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Saeed L; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Hanson CA; Divisions of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Ketterling RP; Division of Cytogenetics, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Pardanani A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Gangat N; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

المصدر: Leukemia [Leukemia] 2017 Dec; Vol. 31 (12), pp. 2851-2852. Date of Electronic Publication: 2017 Aug 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Polycythemia Vera/*pathology , Primary Myelofibrosis/*pathology , Thrombocythemia, Essential/*pathology, Aged ; Female ; Humans ; Janus Kinase 2/metabolism ; Male ; Middle Aged ; Polycythemia Vera/metabolism ; Primary Myelofibrosis/metabolism ; Prognosis ; Thrombocythemia, Essential/metabolism

المؤلفون: Barraco D; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA., Mudireddy M; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA., Shah S; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hanson CA; Department of Hematopathology and Cytogenetics, Mayo Clinic, Rochester, MN, USA., Ketterling RP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Gangat N; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA., Pardanani A; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA., Tefferi A; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.

المصدر: Blood cancer journal [Blood Cancer J] 2017 Apr 21; Vol. 7 (4), pp. e557. Date of Electronic Publication: 2017 Apr 21.

نوع المنشور: Letter

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Databases, Factual*, Liver/*metabolism , Primary Myelofibrosis/*metabolism, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Liver/pathology ; Liver Function Tests ; Male ; Middle Aged ; Primary Myelofibrosis/pathology

المؤلفون: Haider M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Elala YC; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Hanson CA; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

المصدر: Blood cancer journal [Blood Cancer J] 2016 Oct 21; Vol. 6 (10), pp. e487. Date of Electronic Publication: 2016 Oct 21.

نوع المنشور: Letter

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, Primary Myelofibrosis/*diagnosis , Primary Myelofibrosis/*genetics , Receptors, Thrombopoietin/*genetics , Splenomegaly/*diagnosis , Thrombocythemia, Essential/*genetics , Thrombocythemia, Essential/*pathology, Adult ; Aged ; Aged, 80 and over ; Disease Progression ; Female ; Follow-Up Studies ; Genetic Predisposition to Disease ; Humans ; Male ; Middle Aged ; Palpation ; Primary Myelofibrosis/pathology ; Prognosis ; Risk Factors ; Splenomegaly/complications ; Splenomegaly/genetics ; Thrombocythemia, Essential/complications

المؤلفون: Barraco D; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.; Division of Hematology, Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, Udine, Italy., Elala YC; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Lasho TL; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Begna KH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Finke C; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Hanson CA; Division of Hematopathology, Mayo Clinic, Rochester, MN, USA., Ketterling RP; Division of Cytogenetics, Mayo Clinic, Rochester, MN, USA., Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

المصدر: Blood cancer journal [Blood Cancer J] 2016 Apr 08; Vol. 6, pp. e415. Date of Electronic Publication: 2016 Apr 08.

نوع المنشور: Letter

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Association Studies* , Mutation*, Anemia/*etiology , Nuclear Proteins/*genetics , Primary Myelofibrosis/*complications , Primary Myelofibrosis/*genetics , Ribonucleoproteins/*genetics, Anemia/diagnosis ; Humans ; Primary Myelofibrosis/diagnosis ; Primary Myelofibrosis/mortality ; Prognosis ; Splicing Factor U2AF

المؤلفون: Pardanani A; Division of Hematology and Department of Medicine, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Abdelrahman RA; Division of Hematology and Department of Medicine, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Finke C; Division of Hematology and Department of Medicine, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Lasho TT; Division of Hematology and Department of Medicine, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Begna KH; Division of Hematology and Department of Medicine, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Al-Kali A; Division of Hematology and Department of Medicine, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Hogan WJ; Division of Hematology and Department of Medicine, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Litzow MR; Division of Hematology and Department of Medicine, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Hanson CA; Division of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Ketterling RP; Division of Cytogenetics, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Tefferi A; Division of Hematology and Department of Medicine, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

المصدر: Leukemia [Leukemia] 2015 Mar; Vol. 29 (3), pp. 741-4. Date of Electronic Publication: 2014 Nov 11.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Benzamides/*therapeutic use , Calreticulin/*genetics , Primary Myelofibrosis/*drug therapy , Primary Myelofibrosis/*genetics , Protein Kinase Inhibitors/*therapeutic use , Pyrimidines/*therapeutic use , Repressor Proteins/*genetics, Adult ; Aged ; Aged, 80 and over ; Drug Administration Schedule ; Female ; Gene Expression ; Genetic Markers ; Humans ; Janus Kinase 1/genetics ; Janus Kinase 2/genetics ; Male ; Middle Aged ; Mutation ; Primary Myelofibrosis/mortality ; Primary Myelofibrosis/pathology ; Prognosis ; Receptors, Thrombopoietin/genetics ; Survival Analysis

المؤلفون: Guglielmelli P; Laboratorio Congiunto MMPC, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Lasho TL; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Rotunno G; Laboratorio Congiunto MMPC, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Score J; Wessex Reg Genetics Lab, Salisbury, UK., Mannarelli C; Laboratorio Congiunto MMPC, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Pancrazzi A; Laboratorio Congiunto MMPC, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Biamonte F; Laboratorio Congiunto MMPC, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Pardanani A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Zoi K; Haematology Research Laboratory, Biomedical Research Foundation, Academy of Athens, Athens, Greece., Reiter A; III. Medizinische Klinik, Universitätsmedizin Mannheim, Mannheim, Germany., Duncombe A; Department of Haematology, Southampton University Hospital, Southampton, UK., Fanelli T; Laboratorio Congiunto MMPC, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Pietra D; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy., Rumi E; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy., Finke C; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Gangat N; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Ketterling RP; Division of Cytogenetics, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Knudson RA; Division of Cytogenetics, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Hanson CA; Division of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Bosi A; Laboratorio Congiunto MMPC, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Pereira A; Hemotherapy & Hemostasis, Hospital Clínic, Barcelona, Spain., Manfredini R; Centre for Regenerative Medicine 'Stefano Ferrari', University of Modena and Reggio Emilia, Modena, Italy., Cervantes F; Hematology Department, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain., Barosi G; Center for the Study of Myelofibrosis, IRCCS Policlinico S.Matteo Foundation, Pavia, Italy., Cazzola M; Department of Hematology Oncology, IRCCS Policlinico San Matteo Foundation & University of Pavia, Pavia, Italy., Cross NC; Faculty of Medicine, University of Southampton, Southampton, UK., Vannucchi AM; Laboratorio Congiunto MMPC, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Tefferi A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

المصدر: Leukemia [Leukemia] 2014 Sep; Vol. 28 (9), pp. 1804-10. Date of Electronic Publication: 2014 Feb 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, Primary Myelofibrosis/*genetics, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Calreticulin/genetics ; Female ; Humans ; Male ; Middle Aged ; Primary Myelofibrosis/mortality ; Prognosis ; Repressor Proteins/genetics

المؤلفون: Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Guglielmelli P; Laboratorio Congiunto MMPC, Department of experimental and clinical medicine, University of Florence, Florence, Italy., Lasho TL; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Rotunno G; Laboratorio Congiunto MMPC, Department of experimental and clinical medicine, University of Florence, Florence, Italy., Finke C; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Mannarelli C; Laboratorio Congiunto MMPC, Department of experimental and clinical medicine, University of Florence, Florence, Italy., Belachew AA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Pancrazzi A; Laboratorio Congiunto MMPC, Department of experimental and clinical medicine, University of Florence, Florence, Italy., Wassie EA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Ketterling RP; Division of Cytogenetics, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Hanson CA; Division of Hematopathology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Vannucchi AM; Laboratorio Congiunto MMPC, Department of experimental and clinical medicine, University of Florence, Florence, Italy.

المصدر: Leukemia [Leukemia] 2014 Jul; Vol. 28 (7), pp. 1494-500. Date of Electronic Publication: 2014 Feb 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, Calreticulin/*genetics , Primary Myelofibrosis/*genetics , Primary Myelofibrosis/*mortality , Repressor Proteins/*genetics, Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Phenotype ; Prognosis

المؤلفون: Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Lasho TL; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Finke CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Knudson RA; Division of Cytogenetics, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Ketterling R; Division of Cytogenetics, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Hanson CH; Division of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Maffioli M; Division of Hematology, Ospedale di Circolo, Fondazione Macchi, Varese, Italy., Caramazza D; Division of Hematology, Ospedale di Circolo, Fondazione Macchi, Varese, Italy., Passamonti F; Division of Hematology, Ospedale di Circolo, Fondazione Macchi, Varese, Italy., Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

المصدر: Leukemia [Leukemia] 2014 Jul; Vol. 28 (7), pp. 1472-7. Date of Electronic Publication: 2014 Jan 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, Calreticulin/*genetics , Janus Kinase 2/*genetics , Primary Myelofibrosis/*genetics , Receptors, Thrombopoietin/*genetics, Aged ; Aged, 80 and over ; Chromosome Aberrations ; DNA Mutational Analysis ; Female ; Gene Expression ; Humans ; Male ; Middle Aged ; Primary Myelofibrosis/diagnosis ; Primary Myelofibrosis/mortality ; Prognosis

المؤلفون: Tefferi A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Lasho TL; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Finke C; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Belachew AA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Wassie EA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Ketterling RP; Division of Cytogenetics, Mayo Clinic, Rochester, MN, USA., Hanson CA; Division of Hematopathology, Mayo Clinic, Rochester, MN, USA., Pardanani A; Division of Hematology, Mayo Clinic, Rochester, MN, USA.

المصدر: Leukemia [Leukemia] 2014 Jul; Vol. 28 (7), pp. 1568-70. Date of Electronic Publication: 2014 Feb 26.

نوع المنشور: Letter

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, Calreticulin/*genetics , Primary Myelofibrosis/*diagnosis , Primary Myelofibrosis/*genetics, Aged ; Aged, 80 and over ; Female ; Humans ; Janus Kinase 2/genetics ; Male ; Middle Aged ; Phenotype ; Primary Myelofibrosis/mortality ; Prognosis